Skip to main navigation

Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.

Accept and Close

Advanced cell therapies for the sports medicine and severe burn care markets

In the News

About Vericel
Vision Mission & Values Patient Stories Management Team Board of Directors Vericel History Partnering with Vericel
Advanced Cell Therapies
About Cell Therapy MACI Epicel Patents
Clinical Development
Pipeline Clinical Trials Clinical and Scientific Publications Grants
Careers
Open Positions Vericel Benefits
Investor Relations
Press Releases Events & Presentations Quarterly Results Stock Quote & Analyst Coverage Annual Reports & Proxies Statements SEC Filings Corporate Governance Board of Directors FAQ Email Alerts Contact

Investor Relations

A leadership story in the field of advanced cell therapy

Investor Relations

Event Details

2019 Cantor Fitzgerald Global Healthcare Conference

Oct 4, 2019 at 7:45 AM EDT

Listen to webcast

Day High:
Day Low:
Volume:

Company Presentation

Company Presentation - January 2020 3.2 MB

Terms and Conditions of Use | Privacy Policy | Medical Information Request Form

Vericel Corporation 64 Sidney Street, Cambridge, MA 02139
Phone: (617) 588-5555 • Fax: (617) 588-5554 • mail@vcel.com